期刊文献+

紫杉醇与头颈部肿瘤 被引量:1

Paclitaxel and head and neck carcinomas
下载PDF
导出
摘要 为了解紫杉醇治疗鼻咽癌、喉癌及其他头颈部肿瘤的疗效及作用机理 ,本文分析了近年来的文献2 7篇。紫杉醇通过稳定微管、阻断细胞的有丝分裂和增殖 ,从而显著地抑制肿瘤细胞的生长并促进细胞调亡 ,在头颈部肿瘤同期放化疗中能起到放疗增敏作用 ,单独或联合其他抗癌药物治疗亦有较佳的疗效。紫杉醇是一种具有良好抗癌活性的药物 ,随着研究的深入 。 Twenty-seven articles covering about rec ent teen years were reviewed in order to understand the mechanism and important role of paclitaxel in treating nasopharyngeal carcinoma, laryngeal carcinoma and other head and neck carcinomas. Paclitaxel not only can inhibit the growth but also promote the apoptosis of cancer cell by stabilizing microtubules and blocking mitosis and proliferation. Paclitaxel has been regarded as a kind of radiosensitizer during concomitant radiotherapy and chemotherapy on head and neck carcinomas. Paclitaxel is one kind of effective anticancer drugs and will play a more and more important role in head and neck carcinoma therapy.
作者 张帅 肖健云
出处 《中国耳鼻咽喉颅底外科杂志》 CAS 2003年第6期375-378,共4页 Chinese Journal of Otorhinolaryngology-skull Base Surgery
关键词 头颈部肿瘤 伪物疗法 紫杉醇 治疗应用 综述文献 Head and neckneoplasms/drug ther Paclicaxeb/ther use Review literature
  • 相关文献

参考文献4

二级参考文献23

  • 1[3]Forastiere AA, Neuberg D, Taylor SG, et al. Phase Ⅱ evaluation of taxol in advanced head and neck cancer: an eastern cooperative oncology group trial. J Natl Cancer Inst Monogr, 1993,15:181
  • 2[4]Tan EH, Khoo KS, Wee J, et al. Phase Ⅱtrial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma. Ann Oncol ,1999,10(2):235
  • 3[5]Yeo W, Leung TW, Chan AT, et al. A phase Ⅱ study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma. Eur J Cancer ,1998,34(13):2027
  • 4[1]Min H, Hong M, Ma J, et al. A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Biol Phys, 1994,30:1037
  • 5[2]Lee AM, Poon YF, Foo W, et al. Retrospective analysis of 5 037 patients with nasopharyngeal carcinoma treated during 1976~1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phtsy,1992, 23: 261
  • 6[1]Adelstein DJ, Kalish LA, Adams GL, et al.Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study [J]. J Clin Oncol, 1993, 11(11):2136-2142.
  • 7[2]McGuir WP, Rowinsk EK, Rosenhein NB, et al.Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelia neoplasms [J]. Ann Intern Med,1989,111(1):273-279.
  • 8[3]Holm FA, Walters RS, Thierault RL, et al.Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer [J]. J Natl Cancer Inst,1991,83(24):1797-1805.
  • 9[4]Chang AY, Kim K, Glick J, et al.Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study [J]. J Natl Cancer Inst,1993,85(5):388-394.
  • 10[5]Leonard CE, Chan DC, Chou TC, et al. Paclitaxel enhances in vitra radiation sensitivity of squamous carcinoma cell lines of the head neck [J]. Cancer Res,1996,56(22):5189-5204.

共引文献38

同被引文献32

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部